Home/EditForce/Takashi Ono
TO

Takashi Ono

Representative Director, President & CEO

EditForce

Therapeutic Areas

EditForce Pipeline

DrugIndicationPhase
PPR Editor for DM1Myotonic Dystrophy Type 1Preclinical